Molecular and functional analysis of patients with defects of granulocytes

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030379

Enrollment

150

Registered

2023-01-31

Start date

2023-02-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D71

Interventions

Group 1: patients with suspicion of CGD

Eligibility

Sex/Gender

All

Age

1 Days to No maximum

Inclusion criteria

Inclusion criteria: suspected diagnosis CGD or confirmed CGD declaration of consent

Exclusion criteria

Exclusion criteria: Refusal of the declaration of consent

Design outcomes

Primary

Measure	Time frame
diagnosis	—

Countries

Germany

Contacts

Public ContactMyriam Lorenz

Institut für Transfusionsmedizin

myriam.lorenz@uni-ulm.de+49731150599

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026